Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Liver Int ; 25(3): 604-12, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15910498

ABSTRACT

BACKGROUND/AIMS: Bile flow consists of bile salt-dependent bile flow (BSDF), generated by canalicular secretion of bile salts, and bile salt-independent flow (BSIF), probably of combined canalicular and ductular origin. Bile salt transport proteins have been identified in cholangiocytes, suggesting a role in control of BSDF and/or in control of bile salt synthesis through cholehepatic shunting. METHODS: We studied effects of bile duct proliferation under non-cholestatic conditions in multidrug resistance-2 P-glycoprotein (Abcb4)-deficient multidrug resistance gene-2 (Mdr2(-/-)) mice. BSDF and BSIF were determined in wild-type and Mdr2(-/-) mice during infusion of step-wise increasing dosages of tauroursodeoxycholate (TUDC). Cholate synthesis rate was determined by 2H4-cholate dilution. Results were related to expression of transport proteins in liver and intestine. RESULTS: During TUDC infusion, BSDF was increased by approximately 50% and BSIF by approximately 100% in Mdr2(-/-) mice compared with controls. Cholate synthesis rate was unaffected in Mdr2(-/-) mice. Hepatic expression of the apical sodium-dependent bile salt transporter (Asbt), its truncated form (tAsbt) and the multidrug resistance-related protein 3 were upregulated in Mdr2(-/-) mice. CONCLUSIONS: Bile duct proliferation in Mdr2(-/-) mice enhances cholehepatic shunting of bile salts, which is associated with a disproportionally high bile flow but does not affect bile salt synthesis.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B/genetics , Bile Acids and Salts/metabolism , Bile Duct Diseases/metabolism , Bile Duct Diseases/pathology , Bile Ducts/pathology , Animals , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Division , Cholates/pharmacokinetics , Deuterium , Gallbladder/metabolism , Intestines/physiology , Membrane Glycoproteins/genetics , Membrane Glycoproteins/metabolism , Mice , Mice, Mutant Strains , Organic Anion Transporters, Sodium-Dependent/genetics , Organic Anion Transporters, Sodium-Dependent/metabolism , Phospholipids/metabolism , RNA, Messenger/analysis , Symporters/genetics , Symporters/metabolism , ATP-Binding Cassette Sub-Family B Member 4
2.
Eur J Pharm Biopharm ; 58(3): 509-19, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15451525

ABSTRACT

Carriers for non-invasive administration of biologically important antioxidant enzymes Cu,Zn-superoxide dismutase (SOD) and catalase (CAT) were developed. Solubilisation and permeabilities of various soybean phosphatidylcholine/sodium cholate (SPC/NaChol) mixtures, mainly in the form of lipid bilayers, focussing on system properties relevant for non-invasive enzyme delivery were investigated in this work. Static and dynamic light scattering measurements gave information on the behaviour of the systems containing up to 40 mM NaChol and 30.6-1.2 mM SPC in the final suspension. The average size of such mixed aggregates was in the 100-200 nm range. Suspension turbidity decreased by 50% upon increasing nominal molar detergent/lipid ratio to NaChol/SPC = 7 and 1.25, in case of SPC = 1.2 and 19.6 mM, respectively. The effective NaChol/SPC molar ratio in bilayers saturated with the detergent was found to be: R(e)(sat) = 0.70 +/- 0.01; bilayer solubilisation point corresponded to R(e)(sol) = 0.97 +/- 0.02, independently of enzyme loading. Vesicles became very permeable to SOD when membrane bound NaChol concentration exceeded 13.7 mM, in case of total starting lipid concentration of 138 mM diluted to SPC = 19.6 mM. Specifically, we measured a 50% loss of SOD from the vesicles with an aggregate-associated molar detergent ratio NaChol/SPC approximately 0.7, which is near the saturation but well below the solubilisation limit. Calcein efflux from such vesicles was compared with SPC/NaChol/SOD mixed aggregates. Our results should contribute to the future design of vesicle mediated transdermal delivery of antioxidant enzymes.


Subject(s)
Cholates/chemistry , Drug Delivery Systems/methods , Phosphatidylcholines/chemistry , Proteins/chemistry , Sodium Cholate/chemistry , Administration, Cutaneous , Cholates/administration & dosage , Cholates/pharmacokinetics , Macromolecular Substances/administration & dosage , Macromolecular Substances/chemistry , Macromolecular Substances/pharmacokinetics , Permeability/drug effects , Phosphatidylcholines/administration & dosage , Phosphatidylcholines/pharmacokinetics , Proteins/administration & dosage , Proteins/pharmacokinetics , Sodium Cholate/administration & dosage , Sodium Cholate/pharmacokinetics , Solubility/drug effects
3.
Biol Pharm Bull ; 26(12): 1739-43, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14646182

ABSTRACT

The significant inhibitory action of diclofenac formulated in mixed micelles of lecithin with cholate or deoxycholate was observed on the rat hind paw edema induced by carrageenan. In the primary stage, mixed micelle formulation of deoxycholate was more effective compared with that of cholate. However, in the final term, the inhibitory action was similar in both formulations. In a previous study, the flux of diclofenac was greater in the mixed micelle formulation of deoxycholate compared with that of cholate. It was suggested that the permeation rate of diclofenac through skin was proportional to the pharmacological activity. The hind paw edema was quickly inhibited when cyclic monoterpene such as d-limonene or l-menthol was included in the formulations. All the micelle formulations significantly decreased the value of AUC estimated the hind paw thickness-time profile. This suggests that the micelle formulation of cholate in addition to deoxycholate showed significant anti-inflammatory activity to hind paw edema of rats. Incorporation of d-limonene or l-menthol was more effective on the decrease of AUC. A pharmacological study revealed that micelle formulations were able to reduce the skin irritation of chemicals.


Subject(s)
Administration, Cutaneous , Diclofenac/pharmacokinetics , Drug Compounding/methods , Micelles , Monoterpenes/chemistry , Animals , Bile Acids and Salts/administration & dosage , Bile Acids and Salts/chemistry , Biological Availability , Biological Transport/physiology , Carrageenan/administration & dosage , Carrageenan/adverse effects , Cholates/administration & dosage , Cholates/pharmacokinetics , Cyclohexenes , Deoxycholic Acid/administration & dosage , Deoxycholic Acid/pharmacokinetics , Diclofenac/administration & dosage , Drug Evaluation, Preclinical , Edema/chemically induced , Edema/metabolism , Edema/prevention & control , Hindlimb/drug effects , Injections , Irritants/adverse effects , Limonene , Male , Menthol/administration & dosage , Menthol/pharmacokinetics , Monoterpenes/administration & dosage , Rats , Rats, Wistar , Skin/drug effects , Skin/physiopathology , Skin Absorption/drug effects , Terpenes/administration & dosage , Terpenes/pharmacokinetics
4.
Gastroenterology ; 120(1): 151-60, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11208724

ABSTRACT

BACKGROUND & AIMS: Release of neurotensin (NT) from intestines is markedly stimulated by ingested fat, and NT may facilitate lipid digestion and absorption through various actions that are not fully understood. Our recent finding that NT stimulates hepatic output of bile acids only when bile delivery to the intestine is maintained has led us to investigate the effects of NT on bile acid absorption in the rat small intestine. METHODS: We measured the effects of intravenous infusion of NT (3-10 pmol x kg(-1) x min(-1)) on biliary recovery of (3)H-taurocholate ((3)H-TC) and (3)H-cholate administered into proximal and distal intestines or into isolated intestinal segments in situ in biliary fistula rats. To further understand the underlying mechanisms involved, the effects of NT on intestinal absorption of (3)H-D-glucose, (3)H-leucine, (14)C-antipyrine, and (51)Cr-EDTA were investigated by monitoring the absorption of radioactivity into superior mesenteric venous blood. RESULTS: Infusion of NT, at doses that caused near physiologic increases in blood NT levels, increased biliary recovery of (3)H-TC from the jejunum (3.4-fold) and ileum (1.7-fold), but did not enhance absorption of (3)H-cholate. NT also facilitated transcellular uptake of (3)H-glucose and (3)H-leucine and increased paracellular uptake to (51)Cr-EDTA and (3)H-mannitol, but did not alter the absorption rate for (14)C-antipyrine. CONCLUSIONS: These results indicate that NT can exert a facilitative effect on intestinal bile acid absorption and return to liver. This effect of NT may involve increases in paracellular absorption and carrier-mediated transport by mechanisms not yet identified.


Subject(s)
Cholates/pharmacokinetics , Intestinal Absorption/drug effects , Jejunum/metabolism , Neurotensin/pharmacology , Taurocholic Acid/pharmacokinetics , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics , Antipyrine/pharmacokinetics , Chelating Agents/pharmacokinetics , Chromium Radioisotopes , Diuretics, Osmotic/pharmacokinetics , Edetic Acid/pharmacokinetics , Glucose/pharmacokinetics , Ileum/metabolism , Intestinal Mucosa/metabolism , Leucine/pharmacokinetics , Male , Mannitol/pharmacokinetics , Neurotensin/blood , Rats , Rats, Sprague-Dawley , Tritium
SELECTION OF CITATIONS
SEARCH DETAIL
...